Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pichai Raman

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|April 8, 2020
Immunogenicity and Immune Silence in Human CancerMark Yarmarkovich, Alvin Farrel, Artemio Sison, et al.
Journal of Cellular and Molecular Medicine|July 2, 2017
The functional variant rs34330 of CDKN1B is associated with risk of neuroblastomaMario Capasso, Lee D McDaniel, Flora Cimmino, et al.
Plos Computational Biology|October 29, 2020
A transcriptome-based classifier to determine molecular subtypes in medulloblastomaKomal S Rathi, Sherjeel Arif, Mateusz Koptyra, et al.
Cancer Genetics|July 13, 2019
A comparison of survival analysis methods for cancer gene expression RNA-Sequencing dataPichai Raman, Samuel Zimmerman, Komal S Rathi, et al.
JCO Precision Oncology|August 13, 2020
Pediatric Somatic Tumor Sequencing Identifies Underlying Cancer PredispositionSuzanne P MacFarland, Kristin Zelley, Lea F Surrey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2015
Crizotinib Synergizes with Chemotherapy in Preclinical Models of NeuroblastomaKateryna Krytska, Hannah T Ryles, Renata Sano, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 9, 2018
Aggressive triple negative breast cancers have unique molecular signature on the basis of mitochondrial genetic and functional defectsManti Guha, Satish Srinivasan, Pichai Raman, et al.
Frontiers in Oncology|March 27, 2020
CAMKV Is a Candidate Immunotherapeutic Target in <i>MYCN</i> Amplified NeuroblastomaRobyn T Sussman, Jo Lynne Rokita, Kevin Huang, et al.
The Journal of Experimental Medicine|May 28, 2017
Rb family proteins enforce the homeostasis of quiescent hematopoietic stem cells by repressing Socs3 expressionEunsun Kim, Ying Cheng, Elisabeth Bolton-Gillespie, et al.
Science Translational Medicine|March 15, 2019
An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastomaRenata Sano, Kateryna Krytska, Colleen E Larmour, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|April 8, 2020
Immunogenicity and Immune Silence in Human CancerMark Yarmarkovich, Alvin Farrel, Artemio Sison, et al.
Journal of Cellular and Molecular Medicine|July 2, 2017
The functional variant rs34330 of CDKN1B is associated with risk of neuroblastomaMario Capasso, Lee D McDaniel, Flora Cimmino, et al.
Plos Computational Biology|October 29, 2020
A transcriptome-based classifier to determine molecular subtypes in medulloblastomaKomal S Rathi, Sherjeel Arif, Mateusz Koptyra, et al.
Cancer Genetics|July 13, 2019
A comparison of survival analysis methods for cancer gene expression RNA-Sequencing dataPichai Raman, Samuel Zimmerman, Komal S Rathi, et al.
JCO Precision Oncology|August 13, 2020
Pediatric Somatic Tumor Sequencing Identifies Underlying Cancer PredispositionSuzanne P MacFarland, Kristin Zelley, Lea F Surrey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2015
Crizotinib Synergizes with Chemotherapy in Preclinical Models of NeuroblastomaKateryna Krytska, Hannah T Ryles, Renata Sano, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 9, 2018
Aggressive triple negative breast cancers have unique molecular signature on the basis of mitochondrial genetic and functional defectsManti Guha, Satish Srinivasan, Pichai Raman, et al.
Frontiers in Oncology|March 27, 2020
CAMKV Is a Candidate Immunotherapeutic Target in <i>MYCN</i> Amplified NeuroblastomaRobyn T Sussman, Jo Lynne Rokita, Kevin Huang, et al.
The Journal of Experimental Medicine|May 28, 2017
Rb family proteins enforce the homeostasis of quiescent hematopoietic stem cells by repressing Socs3 expressionEunsun Kim, Ying Cheng, Elisabeth Bolton-Gillespie, et al.
Science Translational Medicine|March 15, 2019
An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastomaRenata Sano, Kateryna Krytska, Colleen E Larmour, et al.
Pageof 6